American Portfolios Advisors Moderna, Inc. Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Moderna, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 11,783 shares of MRNA stock, worth $474,501. This represents 0.06% of its overall portfolio holdings.

Number of Shares

11,783

Holding current value

$474,501

% of portfolio

0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$118.07 - $194.18 $1.39 Million - $2.29 Million	11,783 New	11,783 $1.39 Billion
Q2 2022 Mar 20, 2023	SELL	$117.13 - $176.59 $564,917 - $851,693	-4,823 Reduced 40.93%	6,960 $994 Million
Q1 2022 Mar 21, 2023	SELL	$126.46 - $235.05 $596,132 - $1.11 Million	-4,714 Reduced 40.01%	7,069 $1.22 Billion
Q4 2021 Mar 21, 2023	SELL	$225.82 - $368.51 $1.23 Million - $2 Million	-5,427 Reduced 46.06%	6,356 $1.61 Billion
Q3 2021 Mar 22, 2023	SELL	$221.9 - $484.47 $931,758 - $2.03 Million	-4,199 Reduced 35.64%	7,584 $2.92 Billion
Q2 2021 Mar 22, 2023	SELL	$129.91 - $234.98 $845,324 - $1.53 Million	-6,507 Reduced 55.22%	5,276 $1.24 Billion
Q1 2021 Mar 22, 2023	SELL	$109.18 - $185.98 $728,121 - $1.24 Million	-6,669 Reduced 56.6%	5,114 $670 Million
Q4 2020 Mar 22, 2023	SELL	$65.74 - $169.86 $445,059 - $1.15 Million	-6,770 Reduced 57.46%	5,013 $524 Million
Q3 2020 Mar 22, 2023	SELL	$54.34 - $94.85 $515,360 - $899,557	-9,484 Reduced 80.49%	2,299 $163 Million
Q2 2020 Mar 24, 2023	BUY	$29.67 - $80.0 $47,739 - $128,720	1,609 Added 402.25%	2,009 $129 Million
Q1 2020 Mar 24, 2023	SELL	$17.78 - $31.58 $202,389 - $359,475	-11,383 Reduced 96.61%	400 $12 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Moderna, Inc. Transaction History